
India has emerged as a strategic engine for the global Healthcare & Life Sciences (HLS) industry, with 2,400+ Global Capability Centers (GCCs) across the country, including 100+ HLS-focused GCCs. These centers are increasingly moving beyond traditional delivery models to own critical, end-to-end mandates spanning drug discovery, clinical research, pharmacovigilance, regulatory operations, digital health, and AI-led innovation.
With more than 55 leading global HLS and pharmaceutical companies already leveraging India-based GCCs for strategic functions, the country has become deeply embedded in the global HLS value chain. As HLS organizations increasingly look to India not just for talent and cost efficiency, but for innovation, specialized expertise, resilience, and enterprise-wide value creation, the role of the GCC is being fundamentally redefined.
In this eBook, we explore the following topics: